The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,815,725 units of the contraceptive implant Nexplanon 68 mg by January 14, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across various medical product categories.
Generated 3/21/25, 9:48 AM